市場調查報告書
商品編碼
1439506
手術縫線 - 全球市場回顧、競爭格局、市場預測 (2030)Surgical Sutures - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球手術縫線市場規模將於 2023 年達到 35.6 億美元,到 2030 年將達到 52.4 億美元,預計在 2024-2030 年預測期內複合年增長率為 6.64%。 手術縫線需求的增加主要是由於全球手術數量的增加。 此外,這些因素還包括需要手術治療的疾病數量的增加,例如關節炎、脊柱畸形和癌症、非致命傷害的增加、產品批准的擴大以及各種先進手術縫合線的推出。預計將在預測期內加強對縫合線的需求並導致市場擴張。
手術縫線市場動態
由於世界各地外科手術的增加,外科縫線市場目前正在成長動能。 例如,根據全球外科基金會2023年發布的數據,全球約30%的各種適應症引起的疾病可以透過手術治療。
此外,根據世界衛生組織(WHO)2023年發布的統計數據,全球剖腹產率持續上升,佔所有新生兒的21%以上。 報告稱,這一數字預計將進一步增加,到 2030 年,剖腹產將佔所有分娩的約 29%。
因此,手術數量的增加預計將有助於未來幾年手術縫線市場的整體成長。
此外,用於有效閉合手術部位的先進縫合線的推出預計也將在未來幾年推動手術縫合線市場的發展。 例如,2020年6月17日,強生醫療器材公司旗下醫療器材公司DePuy Synthes在歐洲市場推出了DYNACORD縫合線,旨在用於肩袖修復中的軟組織近似等手術。它已在某些部分發布。 與其他可能鬆動的高強度骨科手術縫線不同,DYNACORD 縫線經過專門設計,可在壓迫時縮短,從而最大限度地減少間隙形成。
因此,所有上述因素預計將在預測期內擴大手術縫合線市場。
然而,閉合手術部位和手術傷口的替代裝置的出現以及手術縫合線嚴格的監管審批程序可能會在未來幾年抑制全球手術縫合線市場。
此外,史無前例的 COVID-19 大流行已在早期階段減緩了全球手術縫線市場的發展。 全國範圍內的封鎖、為防止感染傳播而取消和拒絕擇期手術、跨境物流限制導致的供應鏈中斷等正在導致手術縫線市場成長放緩。 根據世界衛生組織 (WHO) 2023 年發布的脈搏調查,約 90% 的國家仍報告基本衛生服務出現一項或多項中斷。 約 20% 的國家可能挽救生命的急診和外科護理仍然受到干擾,反映出這場流行病最直接的間接影響。 此外,三分之二的國家報告暫停了擇期手術,隨著疫情的持續,其影響正在累積。 然而,由於2020年下半年全球多種COVID-19疫苗的批准和管理,包括醫療保健服務在內的各個領域的活動恢復情況有了顯著改善,從而促進了外科手術的增長縫合線市場健康復甦的道路已經鋪平。
手術縫合線市場細分分析
在手術縫線產品類型細分市場中,縫線類別在預測期內佔據了很大份額。 縫線有子類別:可吸收縫線和不可吸收縫線。 可吸收縫合線的廣泛使用是促進市場成長的因素之一。
此外,隨著時間的推移溶解的好處同時為傷口閉合提供足夠的拉伸強度也增加了其需求。
本報告研究和分析了全球手術縫合線市場,提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable And Non Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), by geography, is expected to grow at a significant CAGR forecast till 2030 owing to the increasing surgical procedures across the globe and launch of advanced surgical sutures in the market
The global surgical sutures market was valued at USD 3.56 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 5.24 billion by 2030. The increase in demand for surgical sutures is predominantly attributed to the rise in the volume of surgeries worldwide. Moreover, an increase in various diseases such as arthritis, spinal deformities, cancers, among others which require surgery for their management, a rise in non-fatal injuries, growing approval of products, and launches of various advanced surgical sutures are anticipated to bolster the demand for these sutures thereby leading to an increase in the global market for surgical sutures during the forecasted period.
Surgical Sutures Market Dynamics:
The market for surgical sutures is gaining momentum at present owing to the increase in surgical procedures across the globe. For instance, as per the data published by the Global Surgery Foundation in the year 2023, there are approximately 30% of global disorders caused by various indications can be treated by surgery.
Furthermore, according to the statistics published by the World Health Organization (WHO) in the year 2023, the rate of caesarean section continues to rise globally accounting for more than 21% of all childbirths. As per the report, the number is anticipated to increase and approximately 29% of all births would likely take place by caesarean section by 2030.
Thus, growing surgeries would contribute to the growth of the overall surgical sutures market in the upcoming years.
In addition, the launch of advanced sutures for an efficient closure of the surgical site is also expected to boost the surgical sutures market in the forthcoming years. For instance, on June 17, 2020, DePuy Synthes, the Johnson & Johnson Medical Devices Companies, launched DYNACORD Suture intended to be used in procedures such as soft tissue approximation in rotator cuff repairs in select European markets. Unlike other high-strength orthopaedic sutures which may experience laxity, DYNACORD Suture is specifically designed to shorten when compression is lost, thereby minimizing gap formation.
Hence, all the above-mentioned factors are projected to augment the market for surgical sutures during the forecasted period.
However, the availability of alternative devices for closing the surgical sites and surgery wounds, and stringent regulatory approval process for the surgical sutures is likely to impede the global surgical sutures market in the upcoming years.
In addition, the unprecedented COVID-19 outbreak has slowed down the global market for surgical sutures during the initial phases. Nationwide lockdown, cancelled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of surgical sutures. According to the World Health Organization "pulse survey" published in the year 2023, about 90% of countries are still reporting one or more disruptions to essential health services. Potentially life-saving emergency, critical, and surgical care interventions are still disrupted in about 20% of countries, reflecting the most immediate indirect consequences of the pandemic. Two-thirds of countries also report disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the surgical sutures market.
Surgical Sutures Market Segment Analysis:
Surgical Sutures Market By Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), By Suture Type (Natural And Synthetic), By Suture Filament (Monofilament, Multifilament, And Barbed), By Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Ophthalmic Surgery, Gynaecological Surgery, Others), By End-User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the surgical sutures product type segment, the suture thread category accounted for a significant share during the forecasted period. The suture thread is sub-categorized into absorbable and non - absorbable types. The wide availability of absorbable sutures is one of the factors for increased market growth.
In addition, the advantage of providing sufficient tensile strength for wound closure, while dissolving over time has increased their demand.
Moreover, recommendations by the governmental organization for the use of technologically advanced absorbable surgical sutures would also bolster the demand in the upcoming years. For instance, on June 28, 2022, National Institute for Health and Care Excellence (NICE) has issued new medical technologies guidance (MTG) recommending the use of Plus Sutures developed by Ethicon, a medical device division of Johnson & Johnson, in surgeries within the National Health Service (NHS). Plus Sutures are a range of synthetic, absorbable sutures that are either impregnated with or coated with medical-grade triclosan, a broadspectrum antibacterial agent effective on most common organisms associated with surgical site infection (SSI).
Hence the aforementioned factors are likely to contribute to the market growth in the forthcoming years.
North America is expected to dominate the overall Surgical Sutures Market:
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period. This domination is owing to the rise in various diseases such as bone deformities, cancer, among others leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.
For instance, as per the Centers for Disease Control and Prevention 2022 data, in the US, approximately 24% of all adults, or 58.5 million people, have arthritis in 2020. Moreover, as per the annual report released by the American Joint Replacement Registry (AJRR) in the year 2020, as of July 1, 2020, approximately 2 million hip and knee arthroplasty procedures were performed.
Furthermore, as per the Canadian Institute for Health Information 2022 data, in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed and the demand for both the replacement surgeries continues to increase. Thus, the rise in surgeries as a treatment option for the various disorders would contribute to the surgical sutures market.
Moreover, approval of surgical sutures in the region is also one of the factors responsible for the growth of the surgical sutures during the forecasted period. For instance, in July 2020, SM ENG CO., LTD, received the US FDA approval for its surgical suture, REXSIN (a synthetic absorbable PGA suture) indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures.
Also, in October 2020, FDA gave clearance to StitchKit PARK, a device that enables surgeons to customize the contents of its StitchKit suture-delivery device with the sutures of their choice developed by Origami Surgical.
Thus, the interplay of all the factors in the region is expected to propel the regional surgical sutures market in the forthcoming years.
Additionally, the Asia-pacific region has the future potential for the surgical sutures market. This is due to the rising number of surgeries such as cardiac surgery, caesarean surgery, among others in the region. For instance, as per the 2019 statistics revealed by the Australian Institute of Health and Welfare, about 24% (2.7 million) of the hospital admissions in the country involved elective surgery in the year 2017-2018. Furthermore, improving healthcare structure, rise in disposable incomes, and presence of regional market players such as Gunze Limited, Meril Lifesciences, among others will also contribute to the market growth of surgical sutures in the forthcoming years.
Surgical Sutures Market Key Players:
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmaceutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., ORIGAMI SURGICAL LLC, and others.
Recent Developmental Activities in the Surgical Sutures Market:
On November 24, 2020, Healthium Medtech Limited launched TRUBARB, an absorbable surgical needled suture and a polydioxanone knotless tissue-closure device with a triangular end-stopper.
On November 24, 2020, LSI Solutions, Inc. received FDA approval for RAM® COR-SUTURE® QUICK LOAD® Surgical Suture and COR-SUTURE® QUICK LOAD® Surgical Suture intended for use in the approximation of soft tissue and prosthetic materials.
On September 09, 2020, Smith+Nephew launched HEALICOIL(TM) KNOTLESS Suture Anchor, expanding its revolutionary line of Advanced Healing Solutions for rotator cuff repair.
Key Takeaways from the Surgical Sutures Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Surgical Sutures market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Surgical Sutures Market.
Various opportunities available for the other competitor in the Surgical Sutures Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Surgical Sutures market growth in the coming future?
Target Audience who can be benefited from the Surgical Sutures Market Report Study
Surgical Sutures providers
Research organizations and consulting companies
Surgical Sutures-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Surgical Sutures
Various End-users who want to know more about the Surgical Sutures Market and the latest technological developments in the Surgical Sutures market.
Frequently Asked Questions for the Surgical Sutures Market:
A surgical suture is one of the most common medical devices used by doctors during surgeries. The suture helps in holding body tissues together after a surgery or an injury. The application of a suture essentially involves the use of a needle along with an attached thread.
The global surgical sutures market was valued at USD 3.56 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 5.24 billion by 2030.
The major factors driving the demand for Surgical Sutures are the rising surgical procedures across the globe. In addition, an increase in diseases such as coronary artery diseases, neurovascular disorders, among others which require surgical intervention, a rise in falls and injuries, the launch of various advanced surgical sutures, among others are likely to drive the market during the forecasted period.
Some of the key market players operating in the Surgical Sutures market include Johnson & Johnson, Medtronic, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmaceutica S.A . de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated., Lotus Surgicals., CONMED Corporation., Unisur Lifecare Pvt. Ltd., GUNZE LIMITED., Sutcon Sutures, Bydand Medical, MANI, INC., Samyang Holdings Corporation, META BIOMED CO,. LTD., Healthium Medtech Limited, Dolphin Sutures., and others.
Among all the regions, North America is expected to occupy a major share in the overall surgical sutures market during the forecasted period, 2024-2030. This domination is owing to the rise in chronic diseases leading to a large population undergoing surgeries thereby fuelling the market for surgical sutures in the region. In addition, the presence of key players such as Johnson & Johnson, DemeTECH Corporation, among others active in the development of surgical sutures, and adoption of technologically advanced surgical sutures by healthcare professionals in the region will also contribute to the surgical sutures market.